Sheila S. S. David

Dr. Sheila S. S. David

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
DBDouglas M. Banda
Douglas M. Banda
NNNicole N. Nuñez
Nicole N. Nuñez
MBMichael A. Burnside
Michael A. Burnside
KBKatie M. Bradshaw
Katie M. Bradshaw
SDSheila S. S. David
Sheila S. S. David

15 December 2015 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RWRyan D. Woods
Ryan D. Woods
VOValerie L. O'SHea
Valerie L. O'SHea
ACAurea Chu
Aurea Chu
SCSheng Cao
Sheng Cao
JRJody L. Richards
Jody L. Richards
SDSheila S. S. David
Sheila S. S. David
MutY adenine glycosylases prevent DNA mutations by excising adenine from promutagenic 8-oxo-7,8-dihydroguanine (OG):A mismatches. Here, we describe structural features of the MutY active site bound to an azaribose transition state analog which indicate a catalytic role for Tyr126 and approach of the water nucleophile on the same side as the departing adenine base. The idea that Tyr126 participates in catalysis, recently predicted by modeling calculations, is strongly supported by mutagenesis and by seeing close contact between the hydroxyl group of this residue and the azaribose moiety of the transition state analog. NMR analysis of MutY methanolysis products corroborates a mechanism for adenine removal with retention of stereochemistry. Based on these results, we propose a revised mechanism for MutY that involves two nucleophilic displacement steps akin to the mechanisms accepted for ‘retaining’ O-glycosidases. This new-for-MutY yet familiar mechanism may also be operative in related base excision repair glycosylases and provides a critical framework for analysis of human MutY (MUTYH) variants associated with inherited colorectal cancer.

9 August 2013 in Journal of the American Chemical Society
Verified
Journal Article
Open access
PMPaige L. McKibbin
Paige L. McKibbin
AFAaron Fleming
Aaron Fleming
ATAtif Towheed
Atif Towheed
BHBennett Van Houten
Bennett Van Houten
CBCynthia J. Burrows
Cynthia J. Burrows
SDSheila S. S. David
Sheila S. S. David
An important feature of the common DNA oxidation product 8-oxo-7,8-dihydroguanine (OG) is its susceptibility to further oxidation that produces guanidinohydantoin (Gh) and spiroiminodihydantoin (Sp) lesions. In the presence of amines, G or OG oxidation produces hydantoin amine adducts. Such adducts may form in cells via interception of oxidized intermediates by protein-derived nucleophiles or naturally occurring amines that are tightly associated with DNA. Gh and Sp are known to be substrates for base excision repair (BER) glycosylases; however, large Sp–amine adducts would be expected to be more readily repaired by nucleotide excision repair (NER). A series of Sp adducts differing in the size of the attached amine were synthesized to evaluate the relative processing by NER and BER. The UvrABC complex excised Gh, Sp, and the Sp–amine adducts from duplex DNA, with the greatest efficiency for the largest Sp–amine adducts. The affinity of UvrA for all of the lesion duplexes was found to be similar, whereas the efficiency of UvrB loading tracked with the efficiency of UvrABC excision. In contrast, the human BER glycosylase NEIL1 exhibited robust activity for all Sp–amine adducts irrespective of size. These studies suggest that both NER and BER pathways mediate repair of a diverse set of hydantoin lesions in cells.


1 December 2009 in DNA Repair
Verified
Journal Article
Closed access
SKSucharita Kundu
Sucharita Kundu
MBMegan K. Brinkmeyer
Megan K. Brinkmeyer
ALAlison L. Livingston
Alison L. Livingston
SDSheila S. S. David
Sheila S. S. David

19 August 2012 in Carcinogenesis
Verified
Journal Article
Closed access
ARAlan Raetz
Alan Raetz
YXYali Xie
Yali Xie
SKSucharita Kundu
Sucharita Kundu
MBMegan K. Brinkmeyer
Megan K. Brinkmeyer
CCCindy Chang
Cindy Chang
SDSheila S. S. David
Sheila S. S. David
Biallelic germline mutations in the base excision repair enzyme gene MUTYH lead to multiple colorectal adenomas and carcinomas referred to as MUTYH-associated polyposis. MUTYH removes adenine misincorporated opposite the DNA oxidation product, 8-oxoguanine (OG), thereby preventing accumulation of G:C to T:A transversion mutations. The most common cancer-associated MUTYH variant proteins when expressed in bacteria exhibit reduced OG:A mismatch affinity and adenine removal activity. However, direct evaluation of OG:A mismatch repair efficiency in mammalian cells has not been assessed due to the lack of an appropriate assay. To address this, we developed a novel fluorescence-based assay of OG:A repair and measured the repair capacity of MUTYH-associated polyposis variants expressed in Mutyh-/- mouse embryonic fibroblasts (MEFs). The repair of a single site-specific synthetic lesion in a green fluorescent protein reporter leads to green fluorescent protein expression with co-expression of a red fluorescent protein serving as the transfection control. Cell lines that stably express the MUTYH-associated polyposis variants G382D and Y165C have significantly lower OG:A repair versus wild-type MEFs and MEFs expressing human wild-type MUTYH. The MUTYH allele that encodes the Q324H variant is found at a frequency above 40% in samples from different ethnic groups and has long been considered phenotypically silent but has recently been associated with increased cancer risk in several clinical studies. In vitro analysis of Q324H MUTYH expressed in insect cells showed that it has reduced enzyme activity similar to that of the known cancer variant G382D. Moreover, we find that OG:A repair in MEFs expressing Q324H was significantly lower than wild-type controls, establishing that Q324H is functionally impaired and providing further evidence that this common variant may lead to increased cancer risk.